Buying Time

Aperçu

Bénéficiez gratuitement de Standard pendant 30 jours

5,99 €/mois après la période d’essai. Annulation possible à tout moment
Essayez pour 0,00 €
Plus d'options d'achat

Buying Time

De : Frank Swain
Lu par : Frank Swain
Essayez pour 0,00 €

Renouvellement automatique à 5,99 € mois après 30 jours. Annulation possible chaque mois.

À propos de ce contenu audio

Liz Parrish wants to cure ageing.

She believes that ageing is a disease. She says regulation is stopping researchers from saving lives. But Liz won’t be stopped.

In 2015, her company flew a patient to Colombia for the first treatment of its kind in humans: gene therapy to reverse biological ageing.

Remarkably, they claim it worked.

If that’s correct, then why are we still dying of old age?

Journalist Frank Swain embarks on the hunt for the true story behind this controversial human experiment.

©2023 Audible, Ltd. (P)2023 Audible, Ltd.
Médecine et secteur des soins de santé
Épisodes
  • Ep 1: We Want to Change Everything
    Apr 26 2023

    Liz Parrish wants to cure ageing.

    She believes that ageing is a disease. She says regulation is stopping researchers from saving lives. But Liz won’t be stopped.

    In 2015, her company flew a patient to Colombia for the first treatment of its kind in humans: gene therapy to reverse biological ageing.

    Remarkably, they claim it worked.

    If that’s correct, then why are we still dying of old age?

    Journalist Frank Swain embarks on the hunt for the true story behind this controversial human experiment.

    Afficher plus Afficher moins
    36 min
  • Ep 2: Ask Me Anything
    Apr 26 2023

    After Bioviva’s big announcement, scientists and journalists scramble to figure out the truth. Who is the human guinea pig and what has happened to them?

    Afficher plus Afficher moins
    29 min
  • Ep 3: Scared to Death
    Apr 26 2023

    Where did BioViva get their new drug? Frank ventures into the hills of the Sierra Nevada to find out.

    Afficher plus Afficher moins
    41 min
Aucun commentaire pour le moment